{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:25:19Z","timestamp":1790616319746,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":5578,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.exphem.2006.10.018","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T07:02:53Z","timestamp":1171954973000},"page":"434-442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells"],"prefix":"10.1016","volume":"35","author":[{"given":"Kazunori","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2006.10.018_bib1","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.4049\/jimmunol.147.9.3165","article-title":"The T cell activation antigen CD27 is a member of the nerve growth factor\/tumor necrosis factor receptor gene family","volume":"147","author":"Camerini","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib2","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/eji.1830201223","article-title":"CD27 expression by a distinct subpopulation of human B lymphocytes","volume":"20","author":"Maurer","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib3","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1182\/blood.V85.12.3556.bloodjournal85123556","article-title":"Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells","volume":"85","author":"Ranheim","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.10.018_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.147.1.29","article-title":"A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TcR\/CD3 complex","volume":"147","author":"Hintzen","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib5","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1182\/blood.V82.11.3430.3430","article-title":"Expression and release of CD27 in human B-cell malignancies","volume":"82","author":"van Oers","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.10.018_bib6","first-page":"398","article-title":"CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily","volume":"83","author":"Molica","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2006.10.018_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000070661","article-title":"Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent Non-Hodgkin's lymphoma","volume":"24","author":"Kok","year":"2003","journal-title":"Tumor Biology"},{"key":"10.1016\/j.exphem.2006.10.018_bib8","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.exphem.2005.10.005","article-title":"Expression of CD27-CD70 on early B cell progenitors in the bone marrow: implication for diagnosis and therapy of childhood ALL","volume":"33","author":"Nilsson","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2006.10.018_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/370555a0","article-title":"Processing of tumor necrosis factor-\u03b1 precursor by metalloproteinases","volume":"370","author":"Gearing","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2006.10.018_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/370558a0","article-title":"Regulation of tumor necrosis factor-\u03b1 processing by a metalloproteinase inhibitor","volume":"370","author":"McGeehan","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2006.10.018_bib11","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.182.6.1777","article-title":"Metalloproteinase-mediated release of human Fas ligand","volume":"182","author":"Kayagaki","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2006.10.018_bib12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1172\/JCI7014","article-title":"The soluble CD40-ligand sCD154 in systemic lupus erythematosus","volume":"104","author":"Kato","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2006.10.018_bib13","series-title":"Williams Hematology","first-page":"1017","article-title":"Chronic lymphocytic leukemia and related diseases","author":"Kipps","year":"1995"},{"key":"10.1016\/j.exphem.2006.10.018_bib14","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.V87.7.2615.bloodjournal8772615","article-title":"B-chronic lymphocytic leukemia: a malignancy of anti-self B cells","volume":"87","author":"Caligaris-Cappio","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.10.018_bib15","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.177.4.925","article-title":"Activated T cells induce expression of B7\/BB1 on normal or leukemic B cells through a CD40-dependent signal","volume":"177","author":"Ranheim","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2006.10.018_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/cimm.1995.1031","article-title":"Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L","volume":"161","author":"Ranheim","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.cgt.7700529","article-title":"Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer","volume":"10","author":"Dehari","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.exphem.2006.10.018_bib18","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/nar\/23.19.3816","article-title":"Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase","volume":"23","author":"Kanegae","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2006.10.018_bib19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm0797-808","article-title":"Sensitivity and reproducibility in adenoviral infectious titer determination","volume":"3","author":"Nyberg-Hoffman","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2006.10.018_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI1472","article-title":"Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells","volume":"101","author":"Kato","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2006.10.018_bib21","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.188.9.1691","article-title":"Identification of functional human splenic memory B cells by expression of CD148 and CD27","volume":"188","author":"Tangye","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2006.10.018_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1521-4141(200101)31:1<243::AID-IMMU243>3.0.CO;2-0","article-title":"IgG subclass switch capacity is low in switched and in IgM-only, but high in IgD+IgM+, post-germinal center (CD27+) human B cells","volume":"31","author":"Werner-Favre","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib23","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.188.9.1679","article-title":"Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells","volume":"188","author":"Klein","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2006.10.018_bib24","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.4049\/jimmunol.164.11.5596","article-title":"Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents","volume":"164","author":"Dono","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/eji.1830220224","article-title":"The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis","volume":"22","author":"Loenen","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/bj3210265","article-title":"Membrane protein secretases","volume":"321","author":"Hooper","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.exphem.2006.10.018_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/clin.1996.0106","article-title":"Expression of the activation antigen CD27 in rheumatoid arthritis","volume":"80","author":"Tak","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.exphem.2006.10.018_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-5728(91)90175-7","article-title":"Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients","volume":"35","author":"Hintzen","year":"1991","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02208342","article-title":"Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course","volume":"14","author":"Swaak","year":"1995","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.exphem.2006.10.018_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/clin.1996.0184","article-title":"Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus","volume":"81","author":"Font","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.exphem.2006.10.018_bib31","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.4049\/jimmunol.165.10.5970","article-title":"Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus","volume":"165","author":"Odendahl","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib32","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1128\/IAI.68.5.3036-3039.2000","article-title":"The metalloproteinase inhibitor GI5402 inhibits endotoxin-induced soluble CD27 and CD16 release in healthy humans","volume":"68","author":"Dekkers","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.exphem.2006.10.018_bib33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1367-5931(98)80122-1","article-title":"Matrix metalloproteinases","volume":"2","author":"Johnson","year":"1998","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.exphem.2006.10.018_bib34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0952-7915(99)80046-6","article-title":"T cell co-stimulatory molecules other than CD28","volume":"11","author":"Watts","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/smim.1998.0154","article-title":"Control of lymphocyte function through CD27-CD70 interactions","volume":"10","author":"Lens","year":"1998","journal-title":"Semin Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/cimm.1997.1150","article-title":"CD27\/CD70 interaction contributes to the activation and the function of human autoreactive CD27+ regulatory T cells","volume":"179","author":"Jacquot","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib37","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.4049\/jimmunol.159.6.2652","article-title":"CD154\/CD40 and CD70\/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling","volume":"159","author":"Jacquot","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib38","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.4049\/jimmunol.164.4.1741","article-title":"CD27-mediated activation of murine NK cells","volume":"164","author":"Takeda","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib39","doi-asserted-by":"crossref","first-page":"13353","DOI":"10.1074\/jbc.273.21.13353","article-title":"CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase\/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase","volume":"273","author":"Akiba","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2006.10.018_bib40","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.4049\/jimmunol.161.9.4753","article-title":"NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27","volume":"161","author":"Yamamoto","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib41","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2208::AID-IMMU2208>3.0.CO;2-L","article-title":"The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2","volume":"28","author":"Gravestein","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib42","doi-asserted-by":"crossref","first-page":"9803","DOI":"10.1073\/pnas.96.17.9803","article-title":"Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation","volume":"96","author":"Nakano","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2006.10.018_bib43","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.4049\/jimmunol.165.9.5084","article-title":"TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies","volume":"165","author":"Zapata","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib44","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood.V96.9.2917","article-title":"CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia","volume":"96","author":"Wierda","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.10.018_bib45","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.4049\/jimmunol.153.4.1421","article-title":"Role of CD27 in T cell immune response: analysis by recombinant soluble CD27","volume":"153","author":"Agematsu","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.10.018_bib46","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.4049\/jimmunol.153.12.5422","article-title":"CD27 is a signal-transducing molecule involved in CD45RA+ naive T cell costimulation","volume":"153","author":"Kobata","year":"1994","journal-title":"J Immunol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06007016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06007016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:23:45Z","timestamp":1759566225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X06007016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0301472X06007016"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2006.10.018","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2006.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}